<?xml version="1.0" encoding="UTF-8" ?>    <rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
    <channel>
            <title>RSS Feed</title>
            <description>Welcome to our RSS Feed</description>
            <copyright> 2026</copyright>
            <link>
            https://www.stampedetrial.org
            </link>
            <lastBuildDate>Thu, 09 November 2023 00:00:00</lastBuildDate>
            <pubDate>Thu, 09 November 2023 00:00:00</pubDate>

                <item>
                    <title>Recruitment to STAMPEDE was completed on 31 March 2023. View the final recruitment figures here.</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2023/november-2023/recruitment-to-stampede-was-completed-on-31-march-2023-view-the-final-recruitment-figures-here/</comments>
					<description><![CDATA[Since it opened in 2005, until the final arms closed to recruitment in March 2023 almost 12,000 men have participated in the STAMPEDE trial across 10 ... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2023/november-2023/recruitment-to-stampede-was-completed-on-31-march-2023-view-the-final-recruitment-figures-here/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2023/november-2023/recruitment-to-stampede-was-completed-on-31-march-2023-view-the-final-recruitment-figures-here/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2023/november-2023/recruitment-to-stampede-was-completed-on-31-march-2023-view-the-final-recruitment-figures-here/</guid>
                    <pubDate>Thu, 09 November 2023 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Giving Abiraterone at Early Stages Helps People With Advanced Prostate Cancer to Live Longer</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2023/may-2023/giving-abiraterone-at-early-stages-helps-people-with-advanced-prostate-cancer-to-live-longer/</comments>
					<description><![CDATA[It has previously been shown that adding the drug abiraterone to the standard hormone therapy just after diagnosis improves survival of people with pr... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2023/may-2023/giving-abiraterone-at-early-stages-helps-people-with-advanced-prostate-cancer-to-live-longer/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2023/may-2023/giving-abiraterone-at-early-stages-helps-people-with-advanced-prostate-cancer-to-live-longer/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2023/may-2023/giving-abiraterone-at-early-stages-helps-people-with-advanced-prostate-cancer-to-live-longer/</guid>
                    <pubDate>Thu, 04 May 2023 00:00:00 </pubDate>
                </item>
                <item>
                    <title>RADICALS and STAMPEDE Investigator Meeting pre-ESMO 2022</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2022/october-2022/radicals-and-stampede-investigator-meeting-pre-esmo-2022/</comments>
					<description><![CDATA[Investigators from the RADICALS and STAMPEDE clinical trials met before the ESMO 2022 conference to present and discuss their updated results.... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2022/october-2022/radicals-and-stampede-investigator-meeting-pre-esmo-2022/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2022/october-2022/radicals-and-stampede-investigator-meeting-pre-esmo-2022/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2022/october-2022/radicals-and-stampede-investigator-meeting-pre-esmo-2022/</guid>
                    <pubDate>Tue, 18 October 2022 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Adding Abiraterone to Standard Therapy Helps People With Metastatic Prostate Cancer to Live Longer</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2022/september-2022/adding-abiraterone-to-standard-therapy-helps-people-with-metastatic-prostate-cancer-to-live-longer/</comments>
					<description><![CDATA[Adding the drug abiraterone to standard hormone therapy helps people with prostate cancer that has spread to other parts of the body to live longer. R... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2022/september-2022/adding-abiraterone-to-standard-therapy-helps-people-with-metastatic-prostate-cancer-to-live-longer/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2022/september-2022/adding-abiraterone-to-standard-therapy-helps-people-with-metastatic-prostate-cancer-to-live-longer/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2022/september-2022/adding-abiraterone-to-standard-therapy-helps-people-with-metastatic-prostate-cancer-to-live-longer/</guid>
                    <pubDate>Wed, 21 September 2022 00:00:00 </pubDate>
                </item>
                <item>
                    <title>RADICALS and STAMPEDE CLOSED INVESTIGATOR MEETING</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2022/july-2022/radicals-and-stampede-closed-investigator-meeting/</comments>
					<description><![CDATA[UPDATE of NEW RESULTS, PROGRESS and FUTURE PLANSMonday 05-Sep-2022&#160; &#160; &#160;12:00 – 14:00 GMTPlease contact mrcctu.stampede@ucl.ac.uk to register for the o... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2022/july-2022/radicals-and-stampede-closed-investigator-meeting/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2022/july-2022/radicals-and-stampede-closed-investigator-meeting/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2022/july-2022/radicals-and-stampede-closed-investigator-meeting/</guid>
                    <pubDate>Thu, 28 July 2022 00:00:00 </pubDate>
                </item>
                <item>
                    <title>STAMPEDE Trial Further Results - Adding Radiotherapy Can Benefit Some Patients Whose Prostate Cancer Has Spread</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2022/june-2022/adding-radiotherapy-can-benefit-some-patients-whose-prostate-cancer-has-spread/</comments>
					<description><![CDATA[Adding radiotherapy to standard hormone therapy helps patients with prostate cancer with limited spread of the disease, to live longer. This result fr... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2022/june-2022/adding-radiotherapy-can-benefit-some-patients-whose-prostate-cancer-has-spread/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2022/june-2022/adding-radiotherapy-can-benefit-some-patients-whose-prostate-cancer-has-spread/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2022/june-2022/adding-radiotherapy-can-benefit-some-patients-whose-prostate-cancer-has-spread/</guid>
                    <pubDate>Fri, 10 June 2022 00:00:00 </pubDate>
                </item>
                <item>
                    <title>STAMPEDE Five Year Follow-up Results</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2022/april-2022/stampede-five-year-follow-up-results-article/</comments>
					<description><![CDATA[A five year follow-up of the STAMPEDE abiraterone comparison has been completed, and the results demonstrate that previously reported effects are robu... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2022/april-2022/stampede-five-year-follow-up-results-article/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2022/april-2022/stampede-five-year-follow-up-results-article/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2022/april-2022/stampede-five-year-follow-up-results-article/</guid>
                    <pubDate>Wed, 08 June 2022 00:00:00 </pubDate>
                </item>
                <item>
                    <title>STAMPEDE Radiotherapy Results Films</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2019/june-2019/m1rt-results-videos/</comments>
					<description><![CDATA[Treating the prostate with radiotherapy alongside standard treatment substantially improves survival for some men with advanced prostate cancer, accor... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2019/june-2019/m1rt-results-videos/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2019/june-2019/m1rt-results-videos/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2019/june-2019/m1rt-results-videos/</guid>
                    <pubDate>Thu, 06 June 2019 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Prostate radiotherapy can benefit some men whose cancer has spread</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2018/october-2018/m1rt-results/</comments>
					<description><![CDATA[Treating the prostate with radiotherapy alongside standard treatment substantially improves survival for some men with advanced prostate cancer, accor... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2018/october-2018/m1rt-results/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2018/october-2018/m1rt-results/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2018/october-2018/m1rt-results/</guid>
                    <pubDate>Mon, 22 October 2018 00:00:00 </pubDate>
                </item>
                <item>
                    <title>SCT Clinical Trial of the Year</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2018/may-2018/sct-clinical-trial-of-the-year/</comments>
					<description><![CDATA[The STAMPEDE trial has received the &#39;2017 David Sackett Trial of the Year Award&#39; from the Society for Clinical Trials (SCT).

Each year since 2008, ... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2018/may-2018/sct-clinical-trial-of-the-year/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2018/may-2018/sct-clinical-trial-of-the-year/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2018/may-2018/sct-clinical-trial-of-the-year/</guid>
                    <pubDate>Thu, 24 May 2018 00:00:00 </pubDate>
                </item>
                <item>
                    <title>BMJ UK Research Paper of the Year Award</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2018/may-2018/bmj-award/</comments>
					<description><![CDATA[STAMPEDE has been shortlisted for the BMJ UK Research Paper of the Year award for the second year in a row; the first to be shortlisted twice for diff... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2018/may-2018/bmj-award/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2018/may-2018/bmj-award/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2018/may-2018/bmj-award/</guid>
                    <pubDate>Wed, 09 May 2018 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Which are the best treatments to add to long-term hormone therapy for advanced prostate cancer? </title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2018/april-2018/stampede-plus-stopcap/</comments>
					<description><![CDATA[Docetaxel or abiraterone, in addition to standard care, are very effective treatments for men with prostate cancer due to start long-term hormone ther... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2018/april-2018/stampede-plus-stopcap/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2018/april-2018/stampede-plus-stopcap/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2018/april-2018/stampede-plus-stopcap/</guid>
                    <pubDate>Mon, 23 April 2018 00:00:00 </pubDate>
                </item>
                <item>
                    <title>STAMPEDE Recruits 10,000th Participant</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2018/april-2018/10k-patients/</comments>
					<description><![CDATA[As the STAMPEDE trial recruits its 10,000th participant, we would like to mark this milestone and take the opportunity to thank everyone involved, par... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2018/april-2018/10k-patients/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2018/april-2018/10k-patients/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2018/april-2018/10k-patients/</guid>
                    <pubDate>Tue, 10 April 2018 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Adding docetaxel to hormone therapy is cost-effective for locally-advanced and advanced prostate cancer </title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2018/february-2018/docetaxel-ce/</comments>
					<description><![CDATA[Adding the drug docetaxel to standard hormone therapy is cost-effective when used to treat men with locally-advanced or advanced prostate cancer. This... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2018/february-2018/docetaxel-ce/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2018/february-2018/docetaxel-ce/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2018/february-2018/docetaxel-ce/</guid>
                    <pubDate>Fri, 09 February 2018 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Protocol 17: Updated CRFs</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/december-2017/protocol-17-crf-updates/</comments>
					<description><![CDATA[Selective CRFs were updated for the activation of Protocol 17, these were:
&#160;

PR08 Form 1: Randomisation form
PR08 Form 2: Baseline Assessment For... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/december-2017/protocol-17-crf-updates/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/december-2017/protocol-17-crf-updates/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/december-2017/protocol-17-crf-updates/</guid>
                    <pubDate>Thu, 07 December 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>STAMPEDE General Site CRF Training</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/november-2017/stampede-general-site-crf-training/</comments>
					<description><![CDATA[Please note, training dates are now available for the STAMPEDE General Site CRF training sessions. These sessions are mainly tailored for new staff me... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/november-2017/stampede-general-site-crf-training/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/november-2017/stampede-general-site-crf-training/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/november-2017/stampede-general-site-crf-training/</guid>
                    <pubDate>Tue, 14 November 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>STAMPEDE Twitter Q&amp;A</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/october-2017/twitter-qa/</comments>
					<description><![CDATA[On Wednesday 1 November 2017, we&#39;ll be running a Twitter Q&amp;amp;A session about the STAMPEDE trial - with the hashtag #BeatProstateCancer.
The purpose... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/october-2017/twitter-qa/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/october-2017/twitter-qa/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/october-2017/twitter-qa/</guid>
                    <pubDate>Mon, 23 October 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>New Website</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/september-2017/new-website/</comments>
					<description><![CDATA[As&#160;you have found, STAMPEDE&#39;s new updated website has launched. This website is a tool for stakeholders of the STAMPEDE research, assisting in such as... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/september-2017/new-website/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/september-2017/new-website/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/september-2017/new-website/</guid>
                    <pubDate>Mon, 04 September 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>ESMO Conference</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/september-2017/esmo/</comments>
					<description><![CDATA[Next Friday marks the beginning of the ESMO Congress 2017, where MRC Clinical Trials Unit at UCL will be presenting results from prostate and ovarian ... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/september-2017/esmo/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/september-2017/esmo/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/september-2017/esmo/</guid>
                    <pubDate>Fri, 01 September 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Systematic review confirms that adding abiraterone to hormone therapy improves survival for men whose prostate cancer has spread </title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/august-2017/abi-in-pca-systematic-review/</comments>
					<description><![CDATA[Results of a systematic review including two large trials have confirmed that adding a drug called abiraterone to standard long-term hormone therapy h... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/august-2017/abi-in-pca-systematic-review/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/august-2017/abi-in-pca-systematic-review/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/august-2017/abi-in-pca-systematic-review/</guid>
                    <pubDate>Fri, 11 August 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>PSA Doubling Time Calculator</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/august-2017/psa-doubling-time-calculator/</comments>
					<description><![CDATA[For the purposes of the STAMPEDE trial, an online&#160;PSA&#160;doubling time&#160;value calculator has been&#160;linked to allow sites to calculate&#160;this PSA velocity eas... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/august-2017/psa-doubling-time-calculator/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/august-2017/psa-doubling-time-calculator/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/august-2017/psa-doubling-time-calculator/</guid>
                    <pubDate>Tue, 01 August 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Arm L Activation</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/june-2017/arm-l-activation/</comments>
					<description><![CDATA[The Stampede team are pleased to announce that the &quot;transdermal oestradiol comparison&quot; (Arm L) was activated today (20/06/2017) at 9am. We have 40 sit... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/june-2017/arm-l-activation/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/june-2017/arm-l-activation/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/june-2017/arm-l-activation/</guid>
                    <pubDate>Fri, 02 June 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Upfront abiraterone improves survival for men with prostate cancer </title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/june-2017/abiraterone-results/</comments>
					<description><![CDATA[Giving the drug abiraterone alongside standard hormone therapy improves the survival of men with high-risk or advanced prostate cancer, according to r... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/june-2017/abiraterone-results/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/june-2017/abiraterone-results/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/june-2017/abiraterone-results/</guid>
                    <pubDate>Thu, 01 June 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>PSA Progression Value Calculator</title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/april-2017/psa-progression-value-calculator/</comments>
					<description><![CDATA[For the purposes of the STAMPEDE trial, a PSA progression value calculator has been&#160;created to allow sites to calculate&#160;a unique threshold PSA value f... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/april-2017/psa-progression-value-calculator/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/april-2017/psa-progression-value-calculator/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/april-2017/psa-progression-value-calculator/</guid>
                    <pubDate>Sat, 01 April 2017 00:00:00 </pubDate>
                </item>
                <item>
                    <title>Results from STAMPEDE on adding celecoxib to hormone therapy for men with prostate cancer </title>
                    <comments>https://www.stampedetrial.org/media-section/news/news-stories/2017/march-2017/celecoxib-results/</comments>
					<description><![CDATA[We are pleased to inform you of the survival results from the oncology “celecoxib comparisons” have now been published in The Journal of Clinical Onco... <a href="https://www.stampedetrial.org/media-section/news/news-stories/2017/march-2017/celecoxib-results/">Continue reading</a>]]></description>
                    <link>
                    https://www.stampedetrial.org/media-section/news/news-stories/2017/march-2017/celecoxib-results/
                    </link>
                    <guid>https://www.stampedetrial.org/media-section/news/news-stories/2017/march-2017/celecoxib-results/</guid>
                    <pubDate>Wed, 01 March 2017 00:00:00 </pubDate>
                </item>
        </channel>        
    </rss>

